Tamar Thompson is a health policy and reimbursement strategist with extensive experience working with governmental agencies, private payers, Congressional leaders, and patient advocacy groups to improve patient access to existing and new medical therapies. She has more than 15 years of leadership experience in health care, including the ability to develop strategic and tactical recommendations to ensure optimal reimbursement and market access for products. Tamar currently serves as director of market access strategy public payer policy for Bristol-Myers Squibb Company and sits on the board of directors for Healthy Women as Vice Chair.
Prior to joining Bristol-Myers Squibb Company, Mrs. Thompson served a strategic policy advisor and consultant for three premire Washington DC based firms, ADVI, Kimbell & Associates and Avalere Health, where she managed a diverse portfolio of clients, including medical device, biotech, pharmaceutical, and specialty drug, companies. Preceding her time in Washington DC, Ms. Thompson was Director of Health Policy & Reimbursement at Molecular Insight Pharmaceuticals (MIP) where she was charged with developing and launching reimbursement strategy for cutting-edge molecular diagnostic and therapeutic treatments options. She has also held health policy and reimbursement leadership strategy roles at GE Healthcare and Bracco Diagnostics.